Alterity Therapeutics Limited (ASX:ATH) Annual Report 2020



The latest annual report of Alterity Therapeutics Limited (ATH) was published on 30 Jun 2020. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - ATH Annual Results

Amounts in AUD

Total Revenue
-
Gross Profit
-352.92k
EBIT
-13.93M
Net Tangible Assets
7.15M
Net Income
-13.46M
Capital Expenditures
-16.74k

ATH Income Statement 2020 Annual Report

As per the latest Income Statement of ATH, the Net revenue increased by $NaN (NaN%) compared to the previous period. The operating income in 2020 decreased by $-1.13M (-9%). The net income as per the annual report was -13.46M which decreased by $-1.12M (-9%) compared to previous year.

Income Statement Report (2020/2019)

20202019
Total Revenue-4.95M
Gross Profit-352.92k4.63M
Operating Income-13.93M-12.8M
Income Before Tax-13.46M-12.34M
Net Income-13.46M-12.34M

Balance Sheet - ATH 2020 Annual Report

Read further: ATH Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Alterity Therapeutics Limited showed the company reduced the cash on balance sheet by $-5.20M (-36%). The Net tangible assets of ATH on the balance sheet were at 7.15M which is $-9.40M (-57%) less than previous annual report. The total stockholder equity also decreased by $-9.40M (-57%) compared to previous reporting period.

Balance Sheet Statement Report (2020/2019)

20202019
Cash9.2M14.4M
Total Assets9.91M 19.91M
Long Term Debt--
Total Liabilities2.76M 3.36M
Total Shareholder Equity7.15M16.55M
Net Tangible Assets7.15M16.55M

Cash Flow Statement - ATH 2020 Annual Report

The 2020 annual cash flow statement of Alterity Therapeutics Limited showed that the net income decreased by $-1.12M (-9%) compared to previous reporting period. Also the capital expenditure of ATH decreased by $-9722 (-138%).

As of 2020, the total cash from investing activities was -16.74k and total cash from financing activities was 3.98M.

Cash Flow Statement Report (2020/2019)

20202019
Net Income-13.46M-12.34M
Capital Expenditures-16.74k-7.02k
Dividends Paid--
Total Cash From From Investing Activities-16.74k-7.02k
Total Cash From From Financing Activities3.98M12.72M

Alterity Therapeutics Limited Annual Report History

Income Statement

Income Statement history of Alterity Therapeutics Limited (ASX:ATH)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Total Revenue-4.95M3.13M3.16M
Cost Of Revenue352.92k322.1k224.58k241.89k
Gross Profit-352.92k4.63M2.9M2.91M
Research Development10.1M12.98M6.7M5.7M
Selling General Administrative3.45M4.31M4.34M3.97M
Non Recurring----
Other Operating Expenses44.22k132.97k58.17k126.07k
Total Operating Expenses13.93M17.75M11.32M10.04M
Operating Income-13.93M-12.8M-8.2M-6.88M
Total Other Income Expense Net472.9k457.6k-69.69k-660.21k
Ebit-13.93M-12.8M-8.2M-6.88M
Interest Expense----
Income Before Tax-13.46M-12.34M-8.27M-7.54M
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-13.46M-12.34M-8.27M-7.54M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-13.46M-12.34M-8.27M-7.54M
Net Income Applicable To Common Shares-13.46M-12.34M-8.27M-7.54M

Balance Sheet Statement

Balance Sheet Statement history of Alterity Therapeutics Limited (ASX:ATH)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Cash9.2M14.4M15.24M21.88M
Net Receivables61.32k4.83M3.15M3.04M
Other Current Assets10.25k10.03k9.8k43.99k
Total Current Assets9.84M19.86M18.65M25.25M
Property Plant Equipment71.37k48.75k71.42k30.82k
Total Assets9.91M19.91M18.73M25.28M
Accounts Payable954.03k1.69M1.33M65.05k
Other Current Liab10.96k11.72k11.19k22.15k
Other Liab41.51k34.98k916440
Total Current Liabilities2.71M3.32M2.64M1.59M
Total Liab2.76M3.36M2.64M1.59M
Common Stock160.7M156.63M143.91M144.02M
Retained Earnings-154.42M-141.24M-129.58M-122.65M
Treasury Stock866.12k1.16M1.75M2.32M
Other Stockholder Equity866.12k1.16M1.75M2.32M
Total Stockholder Equity7.15M16.55M16.08M23.69M
Net Tangible Assets7.15M16.55M16.08M23.69M
Long Term Debt----

Cash Flow Statement

Cash Flow Statement history of Alterity Therapeutics Limited (ASX:ATH)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Net Income-13.46M-12.34M-8.27M-7.54M
Depreciation112.43k29.7k21.8k21.33k
Change To Netincome-274.99k-314.74k1.04M680.48k
Change To Account Receivables4.77M-1.68M-116.84k1.75M
Change To Liabilities-648.57k662.93k1.16M-856.13k
Change To Operating Activities68.64k-317.78k-89.88k85.17k
Total Cash From Operating Activities-9.43M-13.95M-6.25M-5.87M
Capital Expenditures-16.74k-7.02k-62.41k-27.92k
Total Cashflows From Investing Activities-16.74k-7.02k-18.42k-27.92k
Net Borrowings-89.24k-89.24k-89.24k-89.24k
Other Cashflows From Financing Activities-292.77k-362.32k-107.68k-159.56k
Total Cash From Financing Activities3.98M12.72M-107.68k-159.56k
Effect Of Exchange Rate262.98k403.88k-278.12k-656.02k
Change In Cash-5.2M-835.65k-6.65M-6.71M
Issuance Of Stock4.36M13.08M13.08M13.08M
Dividends Paid----